首页 › 基金 › HARDING LOEVNER LP › ELV

HARDING LOEVNER LP 对 ELV 的持仓历史

ELEVANCE HEALTH INC FORMERLY · 医疗保健

HARDING LOEVNER LP 在 Q2 2026 的 13F 申报中披露持有 ELV(ELEVANCE HEALTH INC FORMERLY)168,707 股,市值约 US$65.2M,约占其申报组合的 0.61%,在其申报持仓中市值排名第 44 位。 HARDING LOEVNER LP 最近 4 个申报季度中有 4 个季度披露了 ELV 持仓,最早可追溯至 Q3 2025。

最新持仓 (Q2 2026)168.71K 股
申报持仓市值$65.24M
组合权重0.61%
首次申报Q3 2025
最近变动减持
更新于2026-10-24

最后更新: 2026-10-24 · 来源: SEC EDGAR Form 13F-HR

HARDING LOEVNER LP 对 ELV 的持仓演变

HARDING LOEVNER LP 于 Q3 2025 首次披露 ELV 持仓:246,365 股(约 US$79.6M)。 在 4 次申报中,HARDING LOEVNER LP 0 次增持、3 次减持、0 次保持不变。 最近一期申报(Q2 2026)显示持股 168,707 股、市值约 US$65.2M,环比减持 -43,132 股。。

逐季持仓明细

季度股数金额变化
Q3 2025 246.37K $79.61M 新进
Q4 2025 220.72K $77.38M 减持
Q1 2026 211.84K $62.03M 减持
Q2 2026 168.71K $65.24M 减持

折线上的点按变动类型着色;缺失季度表示该季未申报持仓。

关于 ELV 与 13F 数据

ELV(ELEVANCE HEALTH INC FORMERLY)属于医疗保健行业。我们追踪的基金中还有 23 只申报持有 ELV,申报仓位最大的包括:惠灵顿管理集团 (US$3.56B), WELLINGTON MANAGEMENT GROUP LLP (US$3.56B), Sanders Capital, LLC (US$2.25B)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。

其它持有 ELV 的基金

查看 ELV 的全部基金持有人 →

常见问题

How long has HARDING LOEVNER LP held ELV?

HARDING LOEVNER LP has disclosed ELV holdings in 4 of the last 4 reported quarters, going back to Q3 2025.

What is HARDING LOEVNER LP's current position in ELV?

As of Q2 2026, HARDING LOEVNER LP holds 168.71K shares of ELV (ELEVANCE HEALTH INC FORMERLY), valued at $65.24M, representing 0.61% of its reported portfolio and ranking #44.

Has HARDING LOEVNER LP been buying or selling ELV?

In the latest 13F filing (Q2 2026), HARDING LOEVNER LP reduced its position in ELV.

Which other funds hold ELV?

Other major institutional holders of ELV include 惠灵顿管理集团, WELLINGTON MANAGEMENT GROUP LLP, Sanders Capital, LLC, among 23 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.